Thrombosis News and Research

Latest Thrombosis News and Research

Statins show promise for deep vein thrombosis

Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year.

27 Oct 2008

Abdominal venous thrombosis risk factors

Abdominal venous thrombosis may present as BCS or SVT. Hereditary and acquired risk factors have been implicated in the etiopathogenesis of abdominal venous thrombosis.

12 Oct 2008

New devices used to reduce arterial occlusions, provide cardiac support

Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

12 Oct 2008

FDA accepts ATryn biologics license application

The US Food and Drug Administration, or FDA, has accepted for review GTC Biotherapeutics, Inc.'s Biologics License Application, or BLA, for ATryn.

6 Oct 2008

Bayer's new oral anticoagulant Xarelto (Rivaroxaban) gets European licence

A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue' - the prevention of hospital-acquired DVT (deep vein thrombosis).

2 Oct 2008

Medical tourism business projected to grow eightfold by 2010

The number of people in the U.S. who plan to travel abroad for medical care, where the costs for various medical and surgical procedures often are comparatively lower, is projected to increase by eight times by 2010, according to a recent study by the Deloitte Center for Health Solutions, the Pittsburgh Post-Gazette reports.

24 Sep 2008

Americans warned about deep vein thrombosis

Americans have been warned from top experts to learn about and prevent deep vein thrombosis and pulmonary embolism.

16 Sep 2008

Migraine sufferers more at risk of deadly blood clots

According to new research migraine sufferers may be more at risk of developing deadly blood clots in their veins.

16 Sep 2008

FDA assigns priority review to ATryn from GTC Biotherapeutics

The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s Biologic License Application, or BLA, for ATryn.

4 Sep 2008

The role played by drug-eluting stents in reducing acute myocardial infarction

The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.

2 Sep 2008

Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery

The DECREASE III Study which took place in the Netherlands between June 2004 and April 2008, showed that patients treated with Fluvastatin showed an improved cardiac outcome after surgery.

1 Sep 2008

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in 'real world'

In the first study of its kind, a drug-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as safe and effective as one of the most established and widely used types of DES with a durable polymer, in equivalent conditions to everyday clinical practice.

1 Sep 2008

Drug eluting stents: New elements in the debate

Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.

31 Aug 2008

Best use of drug-eluting stents: When should they be avoided?

Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction.

31 Aug 2008

Warfarin may prevent liver failure in hepatitis C

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.

31 Jul 2008

Direct link between air pollution and high blood pressure

The air people breathe while walking in the park, working in the garden or shopping downtown may be unhealthy enough to seriously spike their blood pressure, a new study suggests.

28 Jul 2008

Study examines heparin use following cardioembolic stroke

The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article posted online today that will appear in the September 2008 print issue of Archives of Neurology. However, it appears that anticoagulation with warfarin therapy may safely begin shortly after stroke.

14 Jul 2008

Heat waves when in hospital

Deaths due to high temperatures occur so quickly that patients do not have time to be admitted to hospital. This is why prevention campaigns are necessary to try and reduce the negative effects of the heat on health. This is pointed out in new research undertaken at the Hospital Universitario Gregorio Maranon, Madrid.

10 Jul 2008

Safer, more effective stents will be available next week for patients with clogged arteries

Wake Forest University Baptist Medical Center will be one of the first medical centers in the region to begin using a new generation of drug-coated stents next week following a major study and the Food and Drug Administration's approval of their use.

3 Jul 2008